BNET Industries
Last Fiscal Year Sales:$76.8M
- Public
- SE
Dow Jones Description
Medicinal Chemistry Research & Applied Genetic Analysis Solution Supplier
President & CEO
Torben JorgensenNumber of Employees 336
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
Recent Events
-
Biotage Q3 EPS Decline - Quick Facts
News & Analysis
Filter by
biotage ab - All News and Analysis
Interim Report for Biotage January - June 2009
STOCKHOLM, Sweden -- Regulatory News: Biotage AB (STO:BIOTA) â?¢ Net sales in the second quarter increased by 10 percent to 104.4...
Biotage AB Launches Share Buy-Back
STOCKHOLM, Sweden -- Regulatory News: The board of directors of Biotage AB publ has resolved to start a share buy-back program in accordance with the...
Resolutions at the Annual General Meeting in Biotage AB on April 27, 2009
STOCKHOLM, Sweden -- Regulatory News: At the Annual General Meeting held in Biotage AB (STO:BIOTA)(Reg. No. 556539-3138) on April 27, 2009, the following resolutions were...
Biotage: Interim report January â?? March 2009
STOCKHOLM, Sweden -- Regulatory News: â?¢ Net sales increased by 12 percent to 99.6 MSEK (88.9). At comparable exchange rates sales decreased by 9 percent....
Biotage AB Joins Forces With MultiSynTech GmbH And Enters the Peptide Synthesis Business
STOCKHOLM, Sweden -- Regulatory News: Biotage today announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech's systems and the establishment of a joint development project. The agreements with MultiSynTech...
Sweden's Biotage AB enters peptide synthesis business, signs deal with MultiSynTech GmbH
NORDIC BUSINESS REPORT-17 February 2009-Sweden's Biotage AB enters peptide synthesis business, signs deal with MultiSynTech GmbHC1994-2009 M2 COMMUNICATIONS LTD http://www.m2.com Swedish life science research company Biotage AB (OMX Stockholm:BIOT) announced on Tuesday (17 February) that it has entered into a collaboration with the German company MultiSynTech GmbH. The...
Swedish life science research company Biotage AB posts record 12-month operating profit of SEK50.0m
NORDIC BUSINESS REPORT-10 February 2009-Swedish life science research company Biotage AB posts record 12-month operating profit of SEK50.0mC1994-2009 M2 COMMUNICATIONS LTD http://www.m2.com Swedish life science research company Biotage AB (OMX Stockholm:BIOT) issued its year-end report on Tuesday (10 February), posting a record operating profit of SEK50.0m, as compared to...
Swedish life science research company Biotage AB to close production plant in Virginia
NORDIC BUSINESS REPORT-23 January 2009-Swedish life science research company Biotage AB to close production plant in VirginiaC1994-2009 M2 COMMUNICATIONS LTD http://www.m2.com Swedish life science research company Biotage AB (OMX Stockholm:BIOT) said on Thursday (22 January) that it has decided to outsource all of its instrument production to contract manufacturers...
Biotage Takes Yet Another Step in Streamlining Efforts
- Outsources All Instrument Production to Contract Manufacturers STOCKHOLM, Sweden -- Regulatory News: Biotage (STO:BIOTA) has made the decision to transfer instrument production from its Charlottesville, VA factory in the U.S. to a contract manufacturer. Through this decision, the company takes yet another step to increase efficiency in...
Resolutions at the Extraordinary General Meeting in Biotage AB on November 21, 2008
UPPSALA, Sweden -- Regulatory News: At the Extraordinary General Meeting held in Biotage AB (Reg. No. 556539-3138) on November 21, 2008, the following resolution was passed. Resolution on reduction of statutory reserve The General Meeting resolved to reduce the company's statutory reserve with an amount of SEK...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Torben Jorgensen | President & CEO |
| Mats-Olof Wallin | CFO |
| Lars Backman | Vice President, Corp Dev |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Ove Mattsson | Chairman |
| Anders Rydin | Board of Directors |
| Annika Espander | Board of Directors |
| Axel Broms | Board of Directors |
| Bengt Falk | Board of Directors |
| Bengt Samuelsson | Board of Directors |
| Hans Engblom | Board of Directors |
| Mathias Uhleen | Board of Directors |
| Mathias Uhlen | Board of Directors |
| Per-Gunnar Eriksson | Board of Directors |
| Per-Olof Eriksson | Board of Directors |
| Staffan Lindstrand | Board of Directors |
| Tomas Eklund | Board of Directors |
| Torbrn Joegensen | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | President & CEO | Current |
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | CFO | Current |
| Biotage Incorporated | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Vice President, Corp Dev | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biotage AB | Board of Directors | Current |
| Biotage AB | President & CEO | Former |
| Volume | 0 |
| Shares Outstanding | 0. |
| Market Cap | 0. |
| Year High | 62.50 |
| Year Low | 0.00010 |
| Earnings Per Share | 0.00 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Fifth Street Finance Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 10, 2009about FSC
-
SAIC, Inc. F3Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about SAI
-
Casella Waste Systems Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 03, 2009about CWST
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES


